Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Dec 10;2021(1):353-360.
doi: 10.1182/hematology.2021000314.

Diamond-Blackfan anemia

Lydie M Da Costa  1   2   3   4 , Isabelle Marie  1   5 , Thierry M Leblanc  5
Affiliations
Case Reports

Diamond-Blackfan anemia

Lydie M Da Costa et al. Hematology Am Soc Hematol Educ Program. .

Abstract

Diamond-Blackfan anemia (DBA) is an inherited bone marrow failure syndrome, characterized as a rare congenital bone marrow erythroid hypoplasia (OMIM#105650). Erythroid defect in DBA results in erythroblastopenia in bone marrow as a consequence of maturation blockade between the burst forming unit-erythroid and colony forming unit-erythroid developmental stages, leading to moderate to severe usually macrocytic aregenerative (<20 × 109/L of reticulocytes) anemia. Congenital malformations localized mostly in the cephalic area and in the extremities (thumbs), as well as short stature and cardiac and urogenital tract abnormalities, are a feature of 50% of the DBA-affected patients. A significant increased risk for malignancy has been reported. DBA is due to a defect in the ribosomal RNA (rRNA) maturation as a consequence of a heterozygous mutation in 1 of the 20 ribosomal protein genes. Besides classical DBA, some DBA-like diseases have been identified. The relation between the defect in rRNA maturation and the erythroid defect in DBA has yet to be fully defined. However, recent studies have identified a role for GATA1 either due to a specific defect in its translation or due to its defective regulation by its chaperone HSP70. In addition, excess free heme-induced reactive oxygen species and apoptosis have been implicated in the DBA erythroid phenotype. Current treatment options are either regular transfusions with appropriate iron chelation or treatment with corticosteroids starting at 1 year of age. The only curative treatment for the anemia of DBA to date is bone marrow transplantation. Use of gene therapy as a therapeutic strategy is currently being explored.

PubMed Disclaimer

Conflict of interest statement

Lydie M. Da Costa: no competing financial interests to declare.

Isabelle Marie: no competing financial interests to declare.

Thierry M. Leblanc: no competing financial interests to declare.

Figures

None
Graphical abstract
Figure 1.
Figure 1.
Family tree of the described DBA family.
Figure 2.
Figure 2.
Genes mutated in DBA and DBA-like cases.
See this image and copyright information in PMC

References

    1. Vlachos A, Ball S, Dahl N, et al; Participants of Sixth Annual Daniella Maria Arturi International Consensus Conference. Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference. Br J Haematol. 2008;142(6):859-876. doi:10.1111/j.1365-2141.2008.07269.x. - DOI - PMC - PubMed
    1. Willig TN, Pérignon JL, Gustavsson P, et al.. High adenosine deaminase level among healthy probands of Diamond Blackfan anemia (DBA) cosegregates with the DBA gene region on chromosome 19q13. The DBA Working Group of Société d'Immunologie Pédiatrique (SHIP). Blood. 1998;92(11):4422-4427. - PubMed
    1. Gustavsson P, Klar J, Matsson H, et al.. Familial transient erythroblastopenia of childhood is associated with the chromosome 19q13.2 region but not caused by mutations in coding sequences of the ribosomal protein S19 (RPS19) gene. Br J Haematol. 2002;119(1):261-264. doi:10.1046/j.1365-2141.2002.03776.x. - DOI - PubMed
    1. Ohene-Abuakwa Y, Orfali KA, Marius C, Ball SE. Two-phase culture in Diamond Blackfan anemia: localization of erythroid defect. Blood. 2005;105 (2):838-846. doi:10.1182/blood-2004-03-1016. - DOI - PubMed
    1. Willig T-N, Niemeyer CM, Leblanc T, et al.. Identification of new prognosis factors from the clinical and epidemiologic analysis of a registry of 229 Diamond-Blackfan anemia patients. Pediatr Res. 1999;46(5):553. doi:10.1203/00006450-199911000-00011. - DOI - PubMed

Publication types

Substances